Overexpression of CSN6 promotes the epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma - 20/06/20
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 9 |
| Iconographies | 6 |
| Vidéos | 0 |
| Autres | 0 |
Highlights |
• | Upregulation of CSN6 expression was significantly associated with the progression and poor survival in HCC patients. |
• | CSN6 promotes proliferation, invasion and migration of HCC cells. |
• | CSN6 led to the metastasis and EMT activation through MEK/ERK pathway. |
Summary |
Background and aim |
CSN6, as a critical subunit of the constitutive photomorphogenesis 9 (COP9) signalosome (CSN), has been previously reported to be increased in various cancers; however, its effect in hepatocellular carcinoma (HCC) remains unknown, which is the aim of present study, in terms of its explore the expression and role of CSN6 in HCC.
Methods |
QRT-PCR, Western blot and immunohistochemistry (IHC) were used to examine the expression of CSN6. Kaplan-Meier survival analysis and univariate and multivariate Cox analyses were used to investigate the clinical and prognostic significance of CSN6 expression in HCC patients. Furthermore, the biological function of CSN6 on HCC cell proliferation and migration was investigated through CCK-8, transwell migration and invasion assays. Besides, the associations between CSN6 and epithelial-mesenchymal transition (EMT) were determined.
Results |
CSN6 was increased in HCC tissues, and its overexpression was found to be associated with a poor prognoses for HCC patients. Overexpression of CSN6 promoted processes of HCC cell proliferation, migration, and invasion, while these processes were inhibited when CSN6 was silenced. Additionally, CSN6 was found to promote EMT by inhibiting E-cadherin, which were significantly mitigated via upregulation of Snail as a result of MEK/ERK pathway activation.
Conclusions |
CSN6 up-regulation may play a contributory role in HCC metastasis and poor prognosis via activation of EMT, and may serve as an independent predictor for HCC prognosis.
Le texte complet de cet article est disponible en PDF.Keywords : CSN6, Hepatocellular carcinoma, Prognosis, Epithelial-mesenchymal transition
Plan
Vol 44 - N° 3
P. 340-348 - juin 2020 Retour au numéro
Article précédent
- Baseline resistance associated substitutions in HCV genotype 1 infected cohort treated with Simeprevir, Daclatasvir and Sofosbuvir in Brazil
- Bruna Forte Aguiar, Guilherme Rodrigues Fernandes Campos, João Paulo Vilela Rodrigues, Nayara Nathie Marques, Bárbara Floriano Molina, Cintia Bittar, Fernanda Fernandes Souza, Ana de Lourdes Candolo Martinelli, Paula Rahal, Leonardo Régis Leira Pereira
- Simple blood fibrosis tests reduce unnecessary referrals for specialized evaluations of liver fibrosis in NAFLD and ALD patients
- Thomas Broussier, Adrien Lannes, Floraine Zuberbuhler, Frederic Oberti, Isabelle Fouchard, Gilles Hunault, Paul Cales, Jerome Boursier
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?